Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis.

Frontiers in oncology·2026
Same author

Immunotherapy plus chemotherapy in advanced biliary tract cancers: pros and cons.

Expert review of gastroenterology & hepatology·2026
Same author

The interplay between bile acid metabolism and gut microbiome in biliary tract cancers.

Frontiers in microbiomes·2026
Same author

ASO Visual Abstract: Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis.

Annals of surgical oncology·2026
Same author

Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis.

Annals of surgical oncology·2026
Same author

Uncovering molecular pathways in appendiceal cancer: A comprehensive characterization for precision oncology.

American journal of surgery·2026

関連する実験動画

Updated: Sep 10, 2025

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

550

大腸がんと免疫療法

Farzad Teymouri1, Gagandeep Brar2

  • 1Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA.

Cancer treatment and research
|August 23, 2025
PubMed
まとめ

結腸直腸がん (CRC) は,ますます若い人々に影響を与えている. 免疫療法は,特にマイクロサテライト不安定性高 (MSI-H) または不一致修復欠乏症 (dMMR) の腫瘍を有する患者にとって有望であり,より広範な応用を探索する研究が進行中である.

科学分野:

  • 腫瘍学
  • 免疫学
  • 分子生物学

背景:

  • 結腸直腸がん (CRC) の発生率は世界中で増加しており,若い人群の増加も顕著です.
  • 腫瘍の進行には複雑な分子経路と 免疫回避戦略があり 効果的な治療を阻害します
  • 癌の監視における 免疫系の役割は極めて重要ですが 腫瘍は 免疫の検出と破壊を回避するメカニズムを 開発します

研究 の 目的:

  • 大腸がんにおける現在の免疫療法の見直し
  • CRCの特定の遺伝子サブセットにおける免疫療法の有効性を強調する.
  • CRCの治療における免疫療法の役割を拡大するための新たな研究方向について議論する.

主な方法:

  • CRCの免疫療法に関する臨床試験と研究に関する文献レビュー
  • CRCにおける分子経路と免疫回避メカニズムの分析
  • 免疫療法への反応を予測するバイオマーカーの検査と患者の分層化.

主要な成果:

  • 免疫療法は,マイクロサテライト不安定性高 (MSI- H) または不一致修復性欠陥 (dMMR) の結腸直腸がん患者にとって有意な臨床的利点を示しています.
  • ペムブロリズマブやニボルマブのような承認された薬剤は,これらの患者集団において有効性を示しています.
キーワード:
大腸がん免疫療法マイクロ衛星の不安定性POLE/POLD1 についてTMB-H について

さらに関連する動画

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.3K
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.1K

関連する実験動画

Last Updated: Sep 10, 2025

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

550
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.3K
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.1K
  • 研究では,早期の疾患およびバイオマーカー陰性患者でも併用療法で免疫療法を検討しています.

    • 結論:

    • 腫瘍と免疫の相互作用を理解することは,パーソナライズされたCRC治療の進歩の鍵です.
    • 免疫療法は,CRC患者のサブセットにおいて,重要な治療的進歩を表しています.
    • 将来の研究は,新しいターゲットと組み合わせ戦略を通じて免疫療法の有効性とアクセシビリティを拡大することを目指しています.